Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B

被引:15
作者
Kubo, S
Tanaka, H
Shuto, T
Takemura, S
Yamamoto, T
Kanazawa, A
Uenishi, T
Tanaka, S
Hirohashi, K
Nishiguchi, S
Kinoshita, H
机构
[1] Osaka City Univ, Grad Sch Med, Dept Gastroenterol & Hepatobiliary Pancreat Surg, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Hepatol, Abeno Ku, Osaka 5458585, Japan
关键词
hepatocellular carcinoma; liver resection; hepatitis B virus; alcohol abuse; diabetes mellitus;
D O I
10.1007/s00595-004-2919-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. We compared the clinicopathologic features affecting outcome after surgery for hepatocellular carcinoma (HCC) between patients with concurrent and previous chronic hepatitis B. Methods. Group A consisted of 58 patients with concurrent chronic hepatitis B, defined by seropositivity for the hepatitis B surface antigen (HBsAg), and group B consisted of 18 patients whose HCC was detected after disappearance of the HBsAg. We assessed the influence of various characteristics on outcome. Results. The mean age and percentage of patients suffering from alcohol abuse or diabetes mellitus were significantly greater in group B than in group A, whereas histologic hepatitis activity, hepatic fibrosis, and alanine aminotransferase activity were significantly lower in group B than in group A. The tumor-free survival rates were similar between the two groups, but the risk factors of recurrence differed. In group A, relative youth, high aspartate aminotransferase activity, low platelet count, multiple tumors, large tumor size, portal invasion, cirrhosis, nonanatomic resection, and positive surgical margin were risk factors. In group B, large tumor size and poor differentiation were risk factors. Conclusion. Hepatitis B status, tumor factors, and the type of operation affected cancer recurrence after surgery for HCC in patients with concurrent chronic HBV, as opposed to only tumor factors in patients with previous chronic hepatitis B.
引用
收藏
页码:216 / 222
页数:7
相关论文
共 40 条
[1]   PERSISTENCE OF HEPATITIS-B VIRAL-DNA AFTER SEROLOGICAL RECOVERY FROM HEPATITIS-B VIRUS-INFECTION [J].
BLUM, HE ;
LIANG, TJ ;
GALUN, E ;
WANDS, JR .
HEPATOLOGY, 1991, 14 (01) :56-62
[2]   Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely "occult"? [J].
Bréchot, C ;
Thiers, V ;
Kremsdorf, D ;
Nalpas, B ;
Pol, S ;
Paterlini-Bréchot, P .
HEPATOLOGY, 2001, 34 (01) :194-203
[3]   Occult hepatitis B virus infection: A hidden menace? [J].
Conjeevaram, H ;
Lok, AS .
HEPATOLOGY, 2001, 34 (01) :204-206
[4]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[5]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[6]  
2-E
[7]   Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure [J].
Eguchi, H ;
Umeshita, K ;
Sakon, M ;
Nagano, H ;
Ito, Y ;
Kishimoto, SI ;
Dono, K ;
Nakamori, S ;
Takeda, T ;
Gotoh, M ;
Wakasa, K ;
Matsuura, N ;
Monden, M .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) :1383-1388
[8]   PERSISTENCE OF HEPATITIS-B VIRUS-DNA IN THE LIVER AFTER LOSS OF HBSAG IN CHRONIC HEPATITIS-B [J].
FONG, TL ;
DIBISCEGLIE, AM ;
GERBER, MA ;
WAGGONER, JG ;
HOOFNAGLE, JH .
HEPATOLOGY, 1993, 18 (06) :1313-1318
[9]  
Kato J, 1996, HEPATOLOGY, V23, P389, DOI 10.1002/hep.510230301
[10]  
KOJIMA M, 1977, GASTROENTEROLOGY, V73, P664